When news first broke that Israeli Prime Minister Benjamin Netanyahu had been treated for prostate cancer without public disclosure, the reaction was immediate. Here was one of the most recognizable and scrutinized leaders on the planet quietly undergoing radiation therapy while simultaneously managing a war — and nobody knew. The diagnosis, the treatment, and the successful outcome had all happened before a single headline was written.
What made this story more than a political footnote is what it reveals about prostate cancer itself: how it is found, how it behaves, and why so many men are blindsided by it. Netanyahu’s experience is not unique. It plays out in doctor’s offices around the world every week, in men who feel completely fine right up until a scan reveals otherwise.
Understanding what happened, and what it means for every man over 50, is the real story here.
Netanyahu’s Cancer Diagnosis: What the Medical Report Actually Said
Netanyahu quietly underwent treatment for prostate cancer — and April 24, 2026 marks the first time the longest-serving leader in Israel’s history has acknowledged being diagnosed with cancer. CNN reported that the cancer was diagnosed several months before the public disclosure, and that Netanyahu began undergoing radiation therapy approximately two and a half months before going public — completing the treatment just before the announcement.
The path to that diagnosis began over a year earlier. According to The Jerusalem Post, Netanyahu, 76, underwent surgery on December 29, 2024, for benign enlargement of the prostate. The procedure was successful and without complications. Benign prostatic hyperplasia, or BPH, is a common non-cancerous condition in older men where the prostate gland grows larger and can press on the urinary tract, causing discomfort and urinary difficulties. It is not cancer, and in Netanyahu’s case, the initial tissue removed showed no malignancy.
What happened next is something medical professionals call an incidental finding. An MRI performed as part of routine follow-up after that surgery revealed a tiny lesion, less than 1 centimeter in size, with suspicious characteristics in the prostate. Further examination confirmed it was an early-stage discovery of prostate cancer. This is exactly the scenario that makes routine post-procedure monitoring so valuable — the cancer was never causing symptoms. It was found purely because the doctors were looking closely.
The tumor was a prostatic adenocarcinoma — a cancer that originates in the glandular cells of the prostate — measuring 0.9 centimeters, found to be in very early stages with no spread to other parts of the body.
Which Hospital Treated Netanyahu — and What They Found
Prof. Aharon Popovtzer, who heads the oncology division at Hadassah Medical Center in Jerusalem, confirmed that the finding was discovered several months ago during routine monitoring. According to Ynet News, Popovtzer said: “A few months ago, as part of completely routine follow-up, a 0.9-centimeter finding was incidentally discovered in the prime minister. The prime minister underwent a comprehensive workup, and it became clear that this was a disease at a very early stage.”
Netanyahu was presented with two options at diagnosis: active surveillance or radiation therapy. Active surveillance — essentially close monitoring without immediate treatment — is a legitimate and widely used strategy for very low-risk prostate cancers, particularly in older patients. Netanyahu chose differently. According to Popovtzer, “The prime minister chose the second option and underwent modern, focused radiation treatment at Hadassah Medical Center two and a half months ago. We can say, based on the findings of these tests, that the disease has disappeared. There is no evidence of disease.”
The report stated the treatment was “fully successful,” with complete disappearance of the lesion confirmed by subsequent imaging and laboratory examinations.
Why Netanyahu Kept His Diagnosis Private
In a statement following publication of the report, Netanyahu said he had requested a two-month delay in its release “so that it would not be published at the height of the war, in order not to allow the Iranian terrorist regime to spread further false propaganda against Israel.” He described his decision to choose immediate radiation rather than watchful waiting as consistent with how he approaches threats at every level. He said he underwent targeted treatment that left no trace of the lesion, and described a process that allowed him to read books during sessions and continue working throughout.
The disclosure was notable for another reason: Netanyahu was 76 at the time of diagnosis. According to the American Cancer Society, prostate cancer is especially common in men over 70 — and the disease’s typically slow progression means many older men with low-risk disease are candidates for active surveillance rather than immediate treatment. Netanyahu’s choice of radiation over surveillance, and the outcome it produced, illustrates why the decision is ultimately individual.
What Is the Prognosis for Early-Stage Prostate Cancer?
Netanyahu’s outcome reflects a well-documented reality in oncology: when prostate cancer is caught before it spreads, the odds are overwhelmingly favorable. According to the National Cancer Institute’s SEER program, the 5-year relative survival rate for localized prostate cancer is 100%. That figure isn’t a rounding error — it reflects how slow-moving and treatable this cancer tends to be when confined to the prostate itself.
The 2025 CA: A Cancer Journal for Clinicians study found the overall 5-year relative survival rate for prostate cancer to be 98%, with the 15-year rate at 97%, largely because 83% of men are diagnosed with local-stage or regional-stage disease. The contrast with late-stage disease is stark: prostate cancers detected after they have metastasized to lymph nodes, organs, or bones carry an average five-year survival rate of just 28%. This gap between early and late diagnosis is one of the most dramatic in all of cancer medicine.
Prostate Cancer Signs Men Should Never Ignore
Here is the uncomfortable truth about prostate cancer: many cases progress slowly and cause no symptoms at first, which is why regular screenings are so important. Netanyahu’s case is proof of that — he had no reported symptoms. The cancer was found on imaging during routine follow-up, not because something felt wrong.
But when symptoms do appear, they matter. They often look similar to common, non-life-threatening conditions such as an enlarged prostate or BPH — which is exactly why men dismiss them. Here is what to watch for:
Changes in urinary habits. More frequent trips to the bathroom — especially at night — a weakened stream, difficulty starting urination, or feeling like you can’t fully empty your bladder can all be signs of prostate cancer. These symptoms often get written off as just getting older, or attributed to a benign prostate issue. See a doctor if they persist or worsen.
Blood in urine or semen. The presence of blood in either urine (hematuria) or semen (hematospermia) is a critical red flag. Even small traces require immediate medical attention, as they may signal prostate cancer, infection, or inflammation. This one should never be dismissed as a fluke or waited out.
A burning or painful sensation when urinating or ejaculating. A burning sensation when you urinate may come from BPH or a urinary tract infection, but it’s also a common sign of prostate cancer — particularly when paired with other urinary symptoms.
Sexual health changes. Erectile dysfunction or pain during ejaculation can be early signs of prostate cancer. Since nerves around the prostate are essential for sexual function, cancer can disrupt these processes. Men often attribute these changes to stress or age without ever bringing them up with a doctor — a delay that can cost them.
Persistent pelvic or lower back pain. Persistent pain in the pelvic area, hips, thighs, or lower back can indicate prostate cancer spreading to nearby tissues. Pain in bones and joints can be an indication that prostate cancer has metastasized — which is exactly the outcome early detection is meant to prevent.
Unexplained fatigue or weight loss. Losing weight without trying and fatigue that doesn’t improve with rest and drags on for weeks are not specific to prostate cancer, but they are grounds for a conversation with your doctor, particularly when combined with any of the symptoms above.
The Role of Screening — and When to Start
When prostate cancer is found early — before it has spread beyond the prostate — the five-year survival rate approaches 100%. That number alone makes the case for routine screening more powerfully than any symptom list. One vital tool is the Prostate-Specific Antigen (PSA) blood test, which can reveal prostate issues before symptoms even appear. PSA is a protein produced by the prostate gland — elevated levels in the blood can point to cancer, though they can also reflect BPH or inflammation. Used alongside a digital rectal exam, the PSA test helps doctors detect cancer in its earliest stages, when treatment is most effective.
Men at average risk are recommended to begin having a PSA test at age 50. Earlier screening may be needed for those with a family history of prostate cancer, especially in a direct relative such as a father or brother. Most men can be screened every two to three years, but an annual exam may be recommended following an abnormal test. African American men or men of African descent have nearly double the risk of prostate cancer compared to white men and are advised to discuss screening earlier — as early as age 40 for those at high risk.
Research consistently shows that the men who achieve the best outcomes are often those who had no symptoms at all — because screening found it first. Missing scheduled screenings meaningfully raises cancer risk, which is why this Hearty Soul piece on prostate screening is worth reading before you put off that next appointment.
What This Means for You
Netanyahu’s prostate cancer diagnosis, confirmed at early stage and treated successfully at Hadassah Medical Center’s oncology institute, ended with a clear scan and no evidence of remaining disease. That outcome was not luck. It was the direct result of routine follow-up imaging that caught something tiny, before it could grow or spread. The lesson isn’t complicated: many men tend to prioritize daily responsibilities and downplay symptoms, delaying a visit to the doctor until something feels urgent. But catching health issues when they first appear — or even before symptoms begin — changes outcomes dramatically.
If you’re a man over 50 and haven’t had a PSA conversation with your doctor, that is the single most actionable thing you can take from this story. If you’re already in your 40s with a family history of prostate cancer, that conversation should have happened yesterday. The symptoms listed above are worth knowing, but the bigger truth is that the men who get the best outcomes are often the ones who never had symptoms at all — because screening found it first. Netanyahu’s experience, now public, is as clear a case study in the value of that routine appointment as you’re likely to find.
Disclaimer: This information is not intended to be a substitute for professional medical advice, diagnosis or treatment and is for information only. Always seek the advice of your physician or another qualified health provider with any questions about your medical condition and/or current medication. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.
A.I. Disclaimer: This article was created with AI assistance and edited by a human for accuracy and clarity.
Read More: 12 Ways to Support Mental Health When Facing Prostate Cancer